You are here

OAV101 IT

Broader population could benefit from Novartis spinal muscular atrophy treatment

Clinical Trials Arena

Mon, 01/13/25 - 05:39 pm

Positive data could expand use of Novartis’ gene therapy for SMA

Clinical Trials Arena

Fri, 01/3/25 - 11:02 am

Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint

Clinical Trials Arena

Thu, 01/2/25 - 11:25 am

clinical trials

spinal muscular atrophy